Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device ...

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...

Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial1.Data ...

Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...

CoreWeave CEO Mike Intrator said on “Squawk Box” that the company had to “rightsize” its pricing ahead of the Friday IPO.

CoreWeave is trying to thaw the tech IPO market with one of the biggest offerings in years, but investors have expressed some skepticism.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

Novo Nordisk announced Monday a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the Danish company is currently the leading player. Novo Nordisk said it’s ...

Shenzhen Sea Star Technology Co. Ltd. A-5.23% ¥5.08B Sichuan Jiuzhou Electric Co. Ltd. A-1.87% ¥17B Guoguang Electric Co. Ltd. A 4.54% ¥11.66B Shenzhen Huakong Seg Co. Ltd. A-3.61% ¥3.62B ...

Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has insisted that the changes aren’t primarily about laying off staff.

With as much as $17 billion in sales in 2024, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). This Scandinavian economic behemoth ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...